Literature DB >> 7674455

Comparative plasma disposition kinetics of albendazole, fenbendazole, oxfendazole and their metabolites in adult sheep.

C E Lanusse1, L H Gascon, R K Prichard.   

Abstract

The comparative plasma disposition kinetics of albendazole (ABZ), fenbendazole (FBZ) and oxfendazole (OFZ) following their oral administration (5 mg/kg) to adult sheep was characterized. Jugular blood samples were taken serially over a 144 h period and plasma was analysed by high performance liquid chromatography (HPLC) for ABZ, ABZ sulphoxide (ABZSO) and ABZ sulphone (ABZSO2) (ABZ treatment), and for FBZ, OFZ and FBZ sulphone (FBZSO2) (FBZ and OFZ treatments). While the ABZ parent drug was not detected at any time post-treatment, ABZSO and ABZSO2 were the analytes recovered in plasma after oral administration of ABZ to sheep. The active ABZSO metabolite was the main analyte recovered in plasma (between 0.25 and 60 h post-treatment), accounting for 71% of the total AUC. FBZ, OFZ and FBZSO2 were the analytes detected in plasma following the oral administration of both FBZ and OFZ to sheep. Low concentrations of FBZ were found in plasma between 4 (FBZ treatment) or 8 h (OFZ treatment) and 72 h post-treatment. The plasma profile of each analyte followed a similar pattern after both treatments; OFZ being the main component detected in plasma. The plasma disposition of ABZ metabolites was markedly different to that of FBZ derivatives. ABZSO exhibited faster absorption and a higher Cmax than OFZ (both treatments). Furthermore, while ABZSO declined relatively rapidly in plasma reaching non-detectable concentrations at 60 h post-ABZ administration, OFZ was found in plasma for up to 120 (FBZ treatment) and 144 h (OFZ treatment).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7674455     DOI: 10.1111/j.1365-2885.1995.tb00578.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  13 in total

1.  Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice.

Authors:  Laura Ceballos; Celina Elissondo; Sergio Sánchez Bruni; Guillermo Denegri; Carlos Lanusse; Luis Alvarez
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheep.

Authors:  Luis A Gomez-Puerta; Cesar Gavidia; Maria T Lopez-Urbina; Hector H Garcia; Armando E Gonzalez
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

3.  Patterns of doramectin tissue residue depletion in parasitized vs nonparasitized lambs.

Authors:  Rubén Pérez; Cristina Palma; Maria José Nuñez; Ignacio Cabezas
Journal:  Parasitol Res       Date:  2008-01-16       Impact factor: 2.289

4.  Population Pharmacokinetic Model of Oxfendazole and Metabolites in Healthy Adults following Single Ascending Doses.

Authors:  Thanh Bach; Daryl J Murry; Larissa V Stebounova; Gregory Deye; Patricia Winokur; Guohua An
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

5.  Secretion into Milk of the Main Metabolites of the Anthelmintic Albendazole Is Mediated by the ABCG2/BCRP Transporter.

Authors:  Esther Blanco-Paniagua; Laura Álvarez-Fernández; Alba M Garcia-Lino; Ana I Álvarez; Gracia Merino
Journal:  Antimicrob Agents Chemother       Date:  2022-06-23       Impact factor: 5.938

6.  Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.

Authors:  Cesar M Gavidia; Armando E Gonzalez; Eduardo A Barron; Berenice Ninaquispe; Monica Llamosas; Manuela R Verastegui; Colin Robinson; Robert H Gilman
Journal:  PLoS Negl Trop Dis       Date:  2010-02-23

7.  Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes.

Authors:  Laura Ceballos; Laura Moreno; Luis Alvarez; Laura Shaw; Ian Fairweather; Carlos Lanusse
Journal:  BMC Vet Res       Date:  2010-02-03       Impact factor: 2.741

8.  Evaluation of nitazoxanide and oxfendazole efficacy against cystic echinococcosis in naturally infected sheep.

Authors:  Cesar M Gavidia; Armando E Gonzalez; Luis Lopera; Cesar Jayashi; Roxana Angelats; Eduardo A Barron; Berenice Ninaquispe; Lucia Villarreal; Hector H Garcia; Manuela R Verastegui; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

9.  Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study.

Authors:  Thanh Bach; Shirley Galbiati; Jessie K Kennedy; Gregory Deye; Effie Y H Nomicos; Ellen E Codd; Hector H Garcia; John Horton; Robert H Gilman; Armando E Gonzalez; Patricia Winokur; Guohua An
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

10.  Population Pharmacokinetic-Pharmacodynamic Model of Oxfendazole in Healthy Adults in a Multiple Ascending Dose and Food Effect Study and Target Attainment Analysis.

Authors:  Thanh Bach; Gregory A Deye; Ellen E Codd; John Horton; Patricia Winokur; Guohua An
Journal:  Antimicrob Agents Chemother       Date:  2021-10-04       Impact factor: 5.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.